Projects per year
Search results
-
Active
A phase 3 randomized, double-blind study of ianalumab (VAY736) versus placebo in addition toeltrombopag in patients with primary immune thrombocytopenia (ITP) who had an insufficient response orrelapsed after first line steroid treatment (VAYHIT2
NOVARTIS PHARMACEUTICALS CORPORATION
3/27/24 → 3/31/34
Project: Research project
-
Efgartigimod Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
3/14/24 → 3/31/34
Project: Research project
-
USTMA Registry (P200)
US THROMBOTIC MICROANGIOPATHY ALLIANCE
10/1/23 → 9/30/26
Project: Research project
-
Porphyrias Consortium
MOUNT SINAI SCHOOL OF MEDICINE, NATIONAL INSTITUTES OF HEALTH (NIH)
7/1/23 → 6/30/24
Project: Research project
-
Prospective, Observational, Multicenter Study of Effectiveness of Efanesoctocog Alfa on Long-term Joint Health in Patients with Hemophilia A
5/23/23 → 5/31/28
Project: Research project
-
A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa(Recombinant) for the prevention of Excessive Bleeding in Patients with Congenital Hemophilia A orB with Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedure
LABORATOIRE FRANCAIS DU FRACTIONNEMENT
5/10/23 → 5/31/28
Project: Research project
-
USTMA Registry (P200)
US THROMBOTIC MICROANGIOPATHY ALLIANCE
1/1/23 → 12/31/25
Project: Research project
-
USTMA Registry (P200) master agreement
US THROMBOTIC MICROANGIOPATHY ALLIANCE
12/5/22 → 12/31/25
Project: Research project
-
Finished
Porphyrias Consortium
MOUNT SINAI SCHOOL OF MEDICINE, NATIONAL INSTITUTES OF HEALTH (NIH)
1/1/23 → 6/30/23
Project: Research project
-
Acquired Thrombotic Thrombocytopenic Purpura and Neuropsychologic Complications
9/30/19 → 1/30/23
Project: Research project
-
A Phase 2, Open-Label Study of INCB050465 in Participants WithAutoimmune Hemolytic Anemia
Vercellotti, G. M. & Mazepa, M.
1/10/19 → 4/30/24
Project: Research project
-
-